/IPDQF
IPDQF Stock - ImpediMed Limited
Healthcare|Medical - DevicesOTC
$0.02+0.00%
+$0.00 (+0.00%) • Dec 19
57
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.41
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.59
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.02
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for IPDQF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.02 – $0.02
TARGET (TP)$0.03
STOP LOSS$0.02
RISK/REWARD1:4.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.53
52W High$0.05
52W Low$0.01
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $12.72M | $10.05M | $11.34M | $10.49M | $8.35M |
| Gross Profit | $10.97M | $8.74M | $-13,654,000 | $8.79M | $6.75M |
| Gross Margin | 86.3% | 86.9% | -120.4% | 83.7% | 80.8% |
| Operating Income | $-24,231,000 | $-24,304,000 | $-22,846,000 | $-21,537,000 | $-23,073,000 |
| Net Income | $-23,237,000 | $-19,790,000 | $-20,521,000 | $-19,874,000 | $-20,706,000 |
| Net Margin | -182.6% | -196.9% | -180.9% | -189.4% | -247.9% |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
Company Overview
ImpediMed Limited, a medical software technology company, develops, manufactures, and sells bioimpedance spectroscopy (BIS) devices and software services in Australia, North America, and internationally. The company offers SOZO, a noninvasive BIS device for the assessment of lymphedema and fluid status monitoring of heart failure patients; SFB7, a single-channel, tetrapolar BIS device to analyze body composition in healthy individuals; and ImpediVET, a single-channel, tetrapolar (BIS) device that measures fluid status and tissue composition for veterinary applications. It sells its devices to hospitals and clinics. The company was incorporated in 1999 and is headquartered in Pinkenba, Australia.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
IPDQFBeat Rate
70%
Last 10 quarters
Avg Surprise
+22.9%
EPS vs Estimate
Beats / Misses
7/3
Last 12 quarters
Latest EPS
$-0.00
Q1 2025
EPS Surprise History
Q2 21
+26.9%
$-0.01vs$-0.01
Q4 21
+29.5%
$-0.00vs$-0.01
Q2 22
-2.4%
$-0.00vs$-0.00
Q4 22
-1.5%
$-0.00vs$-0.00
Q2 23
No data
Q2 24
+2.6%
$-0.00vs$-0.00
Q4 24
+18.0%
$-0.00vs$-0.00
Q1 25
+88.0%
$-0.00vs$-0.00
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Feb 24, 2026 | — | — | — | — |
Q1 2025 | Feb 24, 2025 | $-0.00 | $-0.00 | +88.0% | ✓ BEAT |
Q4 2024 | Oct 21, 2024 | $-0.00 | $-0.00 | +18.0% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $-0.00 | $-0.00 | +2.6% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | $-0.00 | $-0.00 | -1.5% | ✗ MISS |
Q2 2022 | Jun 30, 2022 | $-0.00 | $-0.00 | -2.4% | ✗ MISS |
Q4 2021 | Dec 31, 2021 | $-0.01 | $-0.00 | +29.5% | ✓ BEAT |
Q2 2021 | Jun 30, 2021 | $-0.01 | $-0.01 | +26.9% | ✓ BEAT |
Q4 2020 | Dec 31, 2020 | $-0.01 | $-0.01 | +29.6% | ✓ BEAT |
Q2 2020 | Jun 30, 2020 | $-0.02 | $-0.01 | +58.3% | ✓ BEAT |
Q4 2019 | Dec 31, 2019 | $-0.01 | $-0.02 | -19.7% | ✗ MISS |
Q2 2019 | Jun 30, 2019 | — | $-0.02 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-0.02 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-0.02 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-0.03 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-0.03 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-0.03 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-0.03 | — | — |
Q4 2015 | Dec 31, 2015 | — | $-0.03 | — | — |
Latest News
Loading news...
Frequently Asked Questions about IPDQF
What is IPDQF's current stock price?
ImpediMed Limited (IPDQF) is currently trading at $0.02 per share. The stock has moved +0.00% today.
What is the analyst price target for IPDQF?
No analyst price targets are currently available for this stock.
What sector is ImpediMed Limited in?
ImpediMed Limited operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is IPDQF's market cap?
ImpediMed Limited has a market capitalization of $0.04 billion, making it a small-cap company.
Does IPDQF pay dividends?
No, ImpediMed Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBBIXF
Bonus BioGroup Ltd.
$0.08
Mkt Cap: $0.1B
CLIFF
Cordlife Group Limited
$0.10
Mkt Cap: $0.0B
CLYYF
Celyad Oncology S.A.
$0.18
Mkt Cap: $0.0B
CNTMF
Fluent Corp.
$0.06
Mkt Cap: $0.0B
ELXMF
Nova Eye Medical Limited
$0.00
Mkt Cap: $0.0B
FNCH
Finch Therapeutics Group, Inc.
$13.82
Mkt Cap: $0.0B
MRAI
Marpai, Inc.
$0.70
Mkt Cap: $0.0B
PETV
PetVivo Holdings, Inc.
$1.16
Mkt Cap: $0.0B
POSC
Positron Corporation
$1.55
Mkt Cap: $0.0B
PYNKF
Perimeter Medical Imaging AI, Inc.
$0.24
Mkt Cap: $0.0B
Explore stocks similar to IPDQF for comparison